Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

76 Results

Guidelines and Advice

Immune Checkpoint Inhibitor Toxicity Management Clinical Practice Guideline

Status: Current
Version: 1

Mar 2018

Guidelines and Advice

An Endorsement of the ASCO-SNO Guideline on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Status: Current
ID: GL END 9-10
Version: 2

Aug 2022

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2021

Status: Current
ID: PET 2021-1

Jan 2022

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2021

Status: Current
ID: PET 2021-2

Jun 2022

Cancer facts

More cancer cases could be prevented if Ontario adults followed cancer-specific alcohol guidelines

Mar 2018

Guidelines and Advice

Systemic Therapy for Metastatic Urothelial Cancer: An Endorsement of a Portion of the European Association of Urology Guideline on Muscle-Invasive and Metastatic Bladder Cancer

Status: In-Review
ID: GL END 3-24

Aug 2022

Guidelines and Advice

Safe Handling of Hazardous Drugs

Status: Current
ID: GL 16-3
Version: 3

Mar 2022

Guidelines and Advice

18F-FET PET Imaging in Brain Tumours

Status: Current
ID: ES PET 20

Apr 2022

Guidelines and Advice

Systemic therapy for the treatment of adult patients with lower-risk myelodysplastic syndromes

Status: In-Review
ID: 6-13

Mar 2018

Guidelines and Advice

Recommendation Report: Entry and Transfer of Care Criteria for Colorectal Diagnostic Assessment Programs (DAPs) in Ontario

Status: Education and Information
Version: 1

Mar 2018

Guidelines and Advice

Cancer Care Ontario Beyond-Use Date Recommendations Report

Status: Current
ID: N/A
Version: 1

Mar 2018

Guidelines and Advice

Surgical, Radiation, and Systemic Treatments of Patients with Thymic Epithelial Tumours

Status: Current
ID: 7-11
Version: 3

Mar 2022

Pages